FDA approves Zoll Medical's wearable defibrillator

08/25/2009 | American City Business Journals

The FDA has approved a new model of Zoll Medical's LifeVest wearable defibrillator designed to monitor the condition of patients at risk for sudden cardiac arrest. "With the FDA approval of this additional LifeVest model, we are increasing inventory levels to provide improved customer service to support our continued growth," said Richard A. Packer, the company's chairman and CEO.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care